It was a good time for smartphone introductions, with Apple (Nasdaq: AAPL) unveiling the iPhone 4 and Garmin (Nasdaq: GRMN) hitting the market with its Android-flavored Garminfone.

Which one do you think sold more this week?

The answer is Garmin, but that was a trick question. Apple won't be taking pre-orders for its new iPhone until next week. It will hit the street on June 24.

There is naturally plenty of hype -- global hype -- for the iPhone 4. It introduces dual cameras, videoconferencing, and a richer resolution than previous incarnations. Given all of the cool Android phones hitting the market these days, Apple needs to make sure that these annual refreshes matter.

Folks, the iPhone 4 matters.

Briefly in the news
Let's take a quick look at some of the other stories that shaped our week.

  • Procter & Gamble (NYSE: PG) made its Gillette Fusion ProGlide razors and cartridges available in stores on Tuesday. The sticky consumer conglomerate claims that the ProGlide reduces tugging and pulling during the shaving process.
  • JPMorgan Chase raised its price target on Netflix (Nasdaq: NFLX) to $133 from $110. Netflix also showed off a streaming app for iPhones and Web-connected iPod touch players that will hit the market this summer.
  • CVS Caremark (NYSE: CVS) and Walgreen (NYSE: WAG) have always been feuding rivals, but the battle intensified when Walgreen announced that it would no longer participate in CVS Caremark's drug benefits plan on new or renewed plans. CVS Caremark fired back and now it's a full-on pharm fight.

Until next week, I remain,

Rick Munarriz